ATE309235T1 - Hydrolyse-einleitende hydrophobe taxane derivate - Google Patents

Hydrolyse-einleitende hydrophobe taxane derivate

Info

Publication number
ATE309235T1
ATE309235T1 AT02008590T AT02008590T ATE309235T1 AT E309235 T1 ATE309235 T1 AT E309235T1 AT 02008590 T AT02008590 T AT 02008590T AT 02008590 T AT02008590 T AT 02008590T AT E309235 T1 ATE309235 T1 AT E309235T1
Authority
AT
Austria
Prior art keywords
hydrolysis
taxane
hydrocarbon
initiation
taxane derivatives
Prior art date
Application number
AT02008590T
Other languages
English (en)
Inventor
Eric Mayhew
Shaukat Ali
Andrew S Janoff
Original Assignee
Zeneus Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneus Pharma Ltd filed Critical Zeneus Pharma Ltd
Application granted granted Critical
Publication of ATE309235T1 publication Critical patent/ATE309235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02008590T 1995-09-12 1996-09-12 Hydrolyse-einleitende hydrophobe taxane derivate ATE309235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US357595P 1995-09-12 1995-09-12

Publications (1)

Publication Number Publication Date
ATE309235T1 true ATE309235T1 (de) 2005-11-15

Family

ID=21706522

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96930847T ATE216377T1 (de) 1995-09-12 1996-09-12 Hydrolysierbare hydrophobe taxanderivate
AT02008590T ATE309235T1 (de) 1995-09-12 1996-09-12 Hydrolyse-einleitende hydrophobe taxane derivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96930847T ATE216377T1 (de) 1995-09-12 1996-09-12 Hydrolysierbare hydrophobe taxanderivate

Country Status (22)

Country Link
US (1) US5703117A (de)
EP (1) EP0902783B1 (de)
JP (1) JP4192208B2 (de)
KR (1) KR100401220B1 (de)
CN (1) CN1100770C (de)
AT (2) ATE216377T1 (de)
CA (1) CA2231750C (de)
CZ (1) CZ288562B6 (de)
DE (2) DE69620802T2 (de)
DK (2) DK1229030T3 (de)
ES (2) ES2252347T3 (de)
HK (1) HK1016169A1 (de)
HU (1) HU226325B1 (de)
IL (1) IL123595A (de)
MX (1) MX9801871A (de)
NO (1) NO319521B1 (de)
NZ (1) NZ318300A (de)
PL (1) PL187738B1 (de)
PT (1) PT902783E (de)
SK (1) SK283199B6 (de)
TR (1) TR199800443T1 (de)
WO (1) WO1997010234A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) * 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
AU747474C (en) 1997-11-10 2006-09-21 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
KR20010052368A (ko) * 1998-05-20 2001-06-25 질레스피 카롤 신규한 입자 제형
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
JP2002534461A (ja) * 1999-01-12 2002-10-15 クアナム メディカル コーポレイション 水不溶性のパクリタキセル誘導体の投与のための組成物および方法
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6656966B2 (en) 2000-06-22 2003-12-02 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) * 2000-08-29 2003-08-19 Micron Technology, Inc. Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (de) * 2001-10-22 2008-12-31 Viroblock SA Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
US6710195B2 (en) * 2001-11-26 2004-03-23 Supergen, Inc. Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
DE60335279D1 (de) * 2002-06-26 2011-01-20 Medigene Ag Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem
EA200501252A1 (ru) 2003-02-03 2006-02-24 Неофарм, Инк. Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
EP1861070B1 (de) * 2005-02-18 2018-01-17 Abraxis BioScience, LLC Arzneimittel mit verbesserter hydrophobie zur einarbeitung in medizinprodukt
US8173167B2 (en) 2005-04-12 2012-05-08 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
KR20100133475A (ko) * 2008-04-10 2010-12-21 아브락시스 바이오사이언스, 엘엘씨 소수성 탁산 유도체의 조성물 그의 용도
CA2721153C (en) * 2008-04-10 2018-10-02 Abraxis Bioscience, Llc Compositions of hydrophobic taxane derivatives and uses thereof
KR101721281B1 (ko) 2009-09-25 2017-04-10 위스콘신 얼럼나이 리서어치 화운데이션 치료제의 미셀 캡슐화
CN105503844A (zh) * 2015-12-11 2016-04-20 上海大学 C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
KR100378612B1 (ko) * 1992-12-23 2003-04-03 브리스톨-마이어스스퀴브컴파니 신규 측쇄-함유 탁산 및 그의 중간체 화합물
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives

Also Published As

Publication number Publication date
EP0902783A1 (de) 1999-03-24
NO981071L (no) 1998-05-12
KR19990044409A (ko) 1999-06-25
IL123595A0 (en) 1998-10-30
SK283199B6 (sk) 2003-03-04
IL123595A (en) 2000-10-31
MX9801871A (es) 1998-05-31
TR199800443T1 (xx) 1998-06-22
HUP9901433A2 (hu) 2001-04-28
DE69620802T2 (de) 2002-10-10
KR100401220B1 (ko) 2004-03-20
CN1202166A (zh) 1998-12-16
EP0902783A4 (de) 1999-03-24
HUP9901433A3 (en) 2001-05-28
CA2231750C (en) 2006-07-11
CZ71198A3 (cs) 1998-07-15
AU6975696A (en) 1997-04-01
HK1016169A1 (en) 1999-10-29
DK1229030T3 (da) 2006-02-13
PT902783E (pt) 2002-09-30
ES2252347T3 (es) 2006-05-16
CA2231750A1 (en) 1997-03-20
JP2001519755A (ja) 2001-10-23
CN1100770C (zh) 2003-02-05
SK33498A3 (en) 1998-08-05
ES2179208T3 (es) 2003-01-16
WO1997010234A1 (en) 1997-03-20
AU706290B2 (en) 1999-06-10
ATE216377T1 (de) 2002-05-15
JP4192208B2 (ja) 2008-12-10
NZ318300A (en) 1999-08-30
EP0902783B1 (de) 2002-04-17
DE69635428T2 (de) 2006-06-14
CZ288562B6 (cs) 2001-07-11
DK0902783T3 (da) 2002-07-22
PL187738B1 (pl) 2004-09-30
DE69620802D1 (de) 2002-05-23
HU226325B1 (en) 2008-08-28
DE69635428D1 (de) 2005-12-15
NO319521B1 (no) 2005-08-22
US5703117A (en) 1997-12-30
PL325477A1 (en) 1998-07-20
NO981071D0 (no) 1998-03-11

Similar Documents

Publication Publication Date Title
ATE309235T1 (de) Hydrolyse-einleitende hydrophobe taxane derivate
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
DK0975595T3 (da) Kokainanaloger
DK1063234T3 (da) Hydrofobe taxanderivater
PT977564E (pt) Forscolina para promocao da massa corporal magra
DE59611341D1 (de) Verwendung von saccharid-konjugaten
MX9203543A (es) Medicamento.
DE69432607D1 (de) Inhalierbares kontrastmittel
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283D0 (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
EP1229030A3 (de) Hydrolyse-einleitende hydrophobe Taxane Derivate
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
PT1058544E (pt) Inibicao da actividade do tnf
IT1204764B (it) Utilizzazione terapeutica del fruttosio-1,6-difosfato per la protezione nei confronti della tossicita' indotta da somministrazione di antitumorali antraciclinici
IT8620514V0 (it) Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.
MX9603483A (es) Acido micofenolico 6-sustituido y derivados.
MX9709683A (es) Uso de derivados de vitamina d4 para tratamiento contra el cancer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1229030

Country of ref document: EP

EEFA Change of the company name
REN Ceased due to non-payment of the annual fee